Citius Pharmaceuticals Inc vs Teucrium Wheat Fund — how do they compare? Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M), while Teucrium Wheat Fund trades at $24.15. The key difference: Teucrium Wheat Fund is trading nearer its 52-week high, Citius Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| CTXR | WEAT | |
|---|---|---|
Market Cap | $20.01M | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $1.82 | $26.00 |
52-Week Low | $0.48 | $19.88 |
Enterprise Value | $16.23M | — |
Trailing returns across standard periods
Latest headlines on both assets
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →WEAT is a commodity ETF that provides exposure to the price of wheat futures. It employs a laddered strategy across multiple benchmark contracts to mitigate the effects of contango and roll costs inherent in agricultural futures trading.
Read more on WEAT →